Chinese shingles vaccine receives clinical trial approval from Philippines FDA
by Press Release from Outbreak News Today on (#67CE4)
NewsDesk @bactiman63 Chinese vaccine company, Jiangsu Recbio Technology Co., Ltd., announced receiving clinical trial approval for its novel adjuvanted recombinant shingles vaccine, REC610, from the Food and Drug Administration of the Philippines. The study will evaluate the safety and immunogenicity of REC610 in healthy adult subjects aged 40 and above. Shingles is an acute infectious skin [...]
The post Chinese shingles vaccine receives clinical trial approval from Philippines FDA appeared first on Outbreak News Today.